img

Global Inactivated Porcine Parvovirus Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Agriculture

Publisher : MRA | Format : PDF

Global Inactivated Porcine Parvovirus Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

The porcine parvovirus inactivated vaccine is used for preventing a porcine parvovirus disease caused by a porcine parvovirus.
Inactivated Porcine Parvovirus Vaccine report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Inactivated Porcine Parvovirus Vaccine market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Sows and Gilts are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Inactivated Porcine Parvovirus Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Inactivated Porcine Parvovirus Vaccine key manufacturers include Merck Animal Health, HIPRA, Zoetis, Ceva, Bioveta, Boehringer Ingelheim, Harbin Pharmaceutical Group, Wuhan Keqian Biology and DHN, etc. Merck Animal Health, HIPRA, Zoetis are top 3 players and held % sales share in total in 2022.
Inactivated Porcine Parvovirus Vaccine can be divided into <107.0 TCID50/mL and ≥107.0 TCID50/mL, etc. <107.0 TCID50/mL is the mainstream product in the market, accounting for % sales share globally in 2022.
Inactivated Porcine Parvovirus Vaccine is widely used in various fields, such as Sows, Gilts and Boars,, etc. Sows provides greatest supports to the Inactivated Porcine Parvovirus Vaccine industry development. In 2022, global % sales of Inactivated Porcine Parvovirus Vaccine went into Sows filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Inactivated Porcine Parvovirus Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck Animal Health
HIPRA
Zoetis
Ceva
Bioveta
Boehringer Ingelheim
Harbin Pharmaceutical Group
Wuhan Keqian Biology
DHN
China Animal Husbandy Industry
Qilu Animal Health Products Factorys
Shandong HuaHong Biological Engineering
Shanghai Hile Biological
Liaoning Yikang Biological
Jilin Zhengye Biological Product
Segment by Type
<107.0 TCID50/mL
≥107.0 TCID50/mL

Segment by Application


Sows
Gilts
Boars

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Inactivated Porcine Parvovirus Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Inactivated Porcine Parvovirus Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Inactivated Porcine Parvovirus Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Inactivated Porcine Parvovirus Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Inactivated Porcine Parvovirus Vaccine introduction, etc. Inactivated Porcine Parvovirus Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Inactivated Porcine Parvovirus Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Inactivated Porcine Parvovirus Vaccine Market Overview
1.1 Inactivated Porcine Parvovirus Vaccine Product Overview
1.2 Inactivated Porcine Parvovirus Vaccine Market Segment by Type
1.2.1 <107.0 TCID50/mL
1.2.2 ≥107.0 TCID50/mL
1.3 Global Inactivated Porcine Parvovirus Vaccine Market Size by Type
1.3.1 Global Inactivated Porcine Parvovirus Vaccine Market Size Overview by Type (2018-2033)
1.3.2 Global Inactivated Porcine Parvovirus Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Inactivated Porcine Parvovirus Vaccine Forecasted Market Size by Type (2024-2033)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Inactivated Porcine Parvovirus Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Inactivated Porcine Parvovirus Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Inactivated Porcine Parvovirus Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Inactivated Porcine Parvovirus Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Inactivated Porcine Parvovirus Vaccine Sales Breakdown by Type (2018-2023)
2 Global Inactivated Porcine Parvovirus Vaccine Market Competition by Company
2.1 Global Top Players by Inactivated Porcine Parvovirus Vaccine Sales (2018-2023)
2.2 Global Top Players by Inactivated Porcine Parvovirus Vaccine Revenue (2018-2023)
2.3 Global Top Players by Inactivated Porcine Parvovirus Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Inactivated Porcine Parvovirus Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Inactivated Porcine Parvovirus Vaccine Market Competitive Situation and Trends
2.5.1 Inactivated Porcine Parvovirus Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Inactivated Porcine Parvovirus Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Inactivated Porcine Parvovirus Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Inactivated Porcine Parvovirus Vaccine Market
2.8 Key Manufacturers Inactivated Porcine Parvovirus Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Inactivated Porcine Parvovirus Vaccine Status and Outlook by Region
3.1 Global Inactivated Porcine Parvovirus Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2033
3.2 Global Inactivated Porcine Parvovirus Vaccine Historic Market Size by Region
3.2.1 Global Inactivated Porcine Parvovirus Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Inactivated Porcine Parvovirus Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Inactivated Porcine Parvovirus Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Inactivated Porcine Parvovirus Vaccine Forecasted Market Size by Region
3.3.1 Global Inactivated Porcine Parvovirus Vaccine Sales in Volume by Region (2024-2033)
3.3.2 Global Inactivated Porcine Parvovirus Vaccine Sales in Value by Region (2024-2033)
3.3.3 Global Inactivated Porcine Parvovirus Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2033)
4 Global Inactivated Porcine Parvovirus Vaccine by Application
4.1 Inactivated Porcine Parvovirus Vaccine Market Segment by Application
4.1.1 Sows
4.1.2 Gilts
4.1.3 Boars
4.2 Global Inactivated Porcine Parvovirus Vaccine Market Size by Application
4.2.1 Global Inactivated Porcine Parvovirus Vaccine Market Size Overview by Application (2018-2033)
4.2.2 Global Inactivated Porcine Parvovirus Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Inactivated Porcine Parvovirus Vaccine Forecasted Market Size by Application (2024-2033)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Inactivated Porcine Parvovirus Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Inactivated Porcine Parvovirus Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Inactivated Porcine Parvovirus Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Inactivated Porcine Parvovirus Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Inactivated Porcine Parvovirus Vaccine Sales Breakdown by Application (2018-2023)
5 North America Inactivated Porcine Parvovirus Vaccine by Country
5.1 North America Inactivated Porcine Parvovirus Vaccine Historic Market Size by Country
5.1.1 North America Inactivated Porcine Parvovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
5.1.2 North America Inactivated Porcine Parvovirus Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Inactivated Porcine Parvovirus Vaccine Sales in Value by Country (2018-2023)
5.2 North America Inactivated Porcine Parvovirus Vaccine Forecasted Market Size by Country
5.2.1 North America Inactivated Porcine Parvovirus Vaccine Sales in Volume by Country (2024-2033)
5.2.2 North America Inactivated Porcine Parvovirus Vaccine Sales in Value by Country (2024-2033)
6 Europe Inactivated Porcine Parvovirus Vaccine by Country
6.1 Europe Inactivated Porcine Parvovirus Vaccine Historic Market Size by Country
6.1.1 Europe Inactivated Porcine Parvovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
6.1.2 Europe Inactivated Porcine Parvovirus Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Inactivated Porcine Parvovirus Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Inactivated Porcine Parvovirus Vaccine Forecasted Market Size by Country
6.2.1 Europe Inactivated Porcine Parvovirus Vaccine Sales in Volume by Country (2024-2033)
6.2.2 Europe Inactivated Porcine Parvovirus Vaccine Sales in Value by Country (2024-2033)
7 Asia-Pacific Inactivated Porcine Parvovirus Vaccine by Region
7.1 Asia-Pacific Inactivated Porcine Parvovirus Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Inactivated Porcine Parvovirus Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2033
7.1.2 Asia-Pacific Inactivated Porcine Parvovirus Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Inactivated Porcine Parvovirus Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Inactivated Porcine Parvovirus Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Inactivated Porcine Parvovirus Vaccine Sales in Volume by Region (2024-2033)
7.2.2 Asia-Pacific Inactivated Porcine Parvovirus Vaccine Sales in Value by Region (2024-2033)
8 Latin America Inactivated Porcine Parvovirus Vaccine by Country
8.1 Latin America Inactivated Porcine Parvovirus Vaccine Historic Market Size by Country
8.1.1 Latin America Inactivated Porcine Parvovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
8.1.2 Latin America Inactivated Porcine Parvovirus Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Inactivated Porcine Parvovirus Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Inactivated Porcine Parvovirus Vaccine Forecasted Market Size by Country
8.2.1 Latin America Inactivated Porcine Parvovirus Vaccine Sales in Volume by Country (2024-2033)
8.2.2 Latin America Inactivated Porcine Parvovirus Vaccine Sales in Value by Country (2024-2033)
9 Middle East and Africa Inactivated Porcine Parvovirus Vaccine by Country
9.1 Middle East and Africa Inactivated Porcine Parvovirus Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Inactivated Porcine Parvovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
9.1.2 Middle East and Africa Inactivated Porcine Parvovirus Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Inactivated Porcine Parvovirus Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Inactivated Porcine Parvovirus Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Inactivated Porcine Parvovirus Vaccine Sales in Volume by Country (2024-2033)
9.2.2 Middle East and Africa Inactivated Porcine Parvovirus Vaccine Sales in Value by Country (2024-2033)
10 Company Profiles
10.1 Merck Animal Health
10.1.1 Merck Animal Health Company Information
10.1.2 Merck Animal Health Introduction and Business Overview
10.1.3 Merck Animal Health Inactivated Porcine Parvovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Animal Health Inactivated Porcine Parvovirus Vaccine Products Offered
10.1.5 Merck Animal Health Recent Development
10.2 HIPRA
10.2.1 HIPRA Company Information
10.2.2 HIPRA Introduction and Business Overview
10.2.3 HIPRA Inactivated Porcine Parvovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 HIPRA Inactivated Porcine Parvovirus Vaccine Products Offered
10.2.5 HIPRA Recent Development
10.3 Zoetis
10.3.1 Zoetis Company Information
10.3.2 Zoetis Introduction and Business Overview
10.3.3 Zoetis Inactivated Porcine Parvovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Zoetis Inactivated Porcine Parvovirus Vaccine Products Offered
10.3.5 Zoetis Recent Development
10.4 Ceva
10.4.1 Ceva Company Information
10.4.2 Ceva Introduction and Business Overview
10.4.3 Ceva Inactivated Porcine Parvovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Ceva Inactivated Porcine Parvovirus Vaccine Products Offered
10.4.5 Ceva Recent Development
10.5 Bioveta
10.5.1 Bioveta Company Information
10.5.2 Bioveta Introduction and Business Overview
10.5.3 Bioveta Inactivated Porcine Parvovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Bioveta Inactivated Porcine Parvovirus Vaccine Products Offered
10.5.5 Bioveta Recent Development
10.6 Boehringer Ingelheim
10.6.1 Boehringer Ingelheim Company Information
10.6.2 Boehringer Ingelheim Introduction and Business Overview
10.6.3 Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Products Offered
10.6.5 Boehringer Ingelheim Recent Development
10.7 Harbin Pharmaceutical Group
10.7.1 Harbin Pharmaceutical Group Company Information
10.7.2 Harbin Pharmaceutical Group Introduction and Business Overview
10.7.3 Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Products Offered
10.7.5 Harbin Pharmaceutical Group Recent Development
10.8 Wuhan Keqian Biology
10.8.1 Wuhan Keqian Biology Company Information
10.8.2 Wuhan Keqian Biology Introduction and Business Overview
10.8.3 Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Products Offered
10.8.5 Wuhan Keqian Biology Recent Development
10.9 DHN
10.9.1 DHN Company Information
10.9.2 DHN Introduction and Business Overview
10.9.3 DHN Inactivated Porcine Parvovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 DHN Inactivated Porcine Parvovirus Vaccine Products Offered
10.9.5 DHN Recent Development
10.10 China Animal Husbandy Industry
10.10.1 China Animal Husbandy Industry Company Information
10.10.2 China Animal Husbandy Industry Introduction and Business Overview
10.10.3 China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.10.4 China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Products Offered
10.10.5 China Animal Husbandy Industry Recent Development
10.11 Qilu Animal Health Products Factorys
10.11.1 Qilu Animal Health Products Factorys Company Information
10.11.2 Qilu Animal Health Products Factorys Introduction and Business Overview
10.11.3 Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Products Offered
10.11.5 Qilu Animal Health Products Factorys Recent Development
10.12 Shandong HuaHong Biological Engineering
10.12.1 Shandong HuaHong Biological Engineering Company Information
10.12.2 Shandong HuaHong Biological Engineering Introduction and Business Overview
10.12.3 Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Products Offered
10.12.5 Shandong HuaHong Biological Engineering Recent Development
10.13 Shanghai Hile Biological
10.13.1 Shanghai Hile Biological Company Information
10.13.2 Shanghai Hile Biological Introduction and Business Overview
10.13.3 Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Products Offered
10.13.5 Shanghai Hile Biological Recent Development
10.14 Liaoning Yikang Biological
10.14.1 Liaoning Yikang Biological Company Information
10.14.2 Liaoning Yikang Biological Introduction and Business Overview
10.14.3 Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Products Offered
10.14.5 Liaoning Yikang Biological Recent Development
10.15 Jilin Zhengye Biological Product
10.15.1 Jilin Zhengye Biological Product Company Information
10.15.2 Jilin Zhengye Biological Product Introduction and Business Overview
10.15.3 Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Products Offered
10.15.5 Jilin Zhengye Biological Product Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Inactivated Porcine Parvovirus Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Inactivated Porcine Parvovirus Vaccine Industrial Chain Analysis
11.4 Inactivated Porcine Parvovirus Vaccine Market Dynamics
11.4.1 Inactivated Porcine Parvovirus Vaccine Industry Trends
11.4.2 Inactivated Porcine Parvovirus Vaccine Market Drivers
11.4.3 Inactivated Porcine Parvovirus Vaccine Market Challenges
11.4.4 Inactivated Porcine Parvovirus Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Inactivated Porcine Parvovirus Vaccine Distributors
12.3 Inactivated Porcine Parvovirus Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of <107.0 TCID50/mL
Table 2. Major Company of ≥107.0 TCID50/mL
Table 3. Global Inactivated Porcine Parvovirus Vaccine Sales by Type 2018 VS 2022 VS 2033 (US$ Million)
Table 4. Global Inactivated Porcine Parvovirus Vaccine Sales by Type (2018-2023) & (M Doses)
Table 5. Global Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Type (2018-2023)
Table 6. Global Inactivated Porcine Parvovirus Vaccine Sales by Type (2018-2023) & (US& Million)
Table 7. Global Inactivated Porcine Parvovirus Vaccine Market Share in Value by Type (2018-2023)
Table 8. Global Inactivated Porcine Parvovirus Vaccine Price by Type (2018-2023) & (US$/K Doses)
Table 9. Global Inactivated Porcine Parvovirus Vaccine Sales by Type (2024-2033) & (M Doses)
Table 10. Global Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Type (2024-2033)
Table 11. Global Inactivated Porcine Parvovirus Vaccine Sales by Type (2024-2033) & (US$ Million)
Table 12. Global Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Type (2024-2033)
Table 13. Global Inactivated Porcine Parvovirus Vaccine Price by Type (2024-2033) & (US$/K Doses)
Table 14. North America Inactivated Porcine Parvovirus Vaccine Sales by Type (2018-2023) & (M Doses)
Table 15. North America Inactivated Porcine Parvovirus Vaccine Sales by Type (2018-2023) & (US$ Million)
Table 16. Europe Inactivated Porcine Parvovirus Vaccine Sales (M Doses) by Type (2018-2023)
Table 17. Europe Inactivated Porcine Parvovirus Vaccine Sales by Type (2018-2023) & (US$ Million)
Table 18. Asia-Pacific Inactivated Porcine Parvovirus Vaccine Sales (M Doses) by Type (2018-2023)
Table 19. Asia-Pacific Inactivated Porcine Parvovirus Vaccine Sales by Type (2018-2023) & (US$ Million)
Table 20. Latin America Inactivated Porcine Parvovirus Vaccine Sales (M Doses) by Type (2018-2023)
Table 21. Latin America Inactivated Porcine Parvovirus Vaccine Sales by Type (2018-2023) & (US$ Million)
Table 22. Middle East and Africa Inactivated Porcine Parvovirus Vaccine Sales (M Doses) by Type (2018-2023)
Table 23. Middle East and Africa Inactivated Porcine Parvovirus Vaccine Sales by Type (2018-2023) & (US$ Million)
Table 24. Global Inactivated Porcine Parvovirus Vaccine Sales by Company (2018-2023) & (M Doses)
Table 25. Global Inactivated Porcine Parvovirus Vaccine Sales Share by Company (2018-2023)
Table 26. Global Inactivated Porcine Parvovirus Vaccine Revenue by Company (2018-2023) & (US$ Million)
Table 27. Global Inactivated Porcine Parvovirus Vaccine Revenue Share by Company (2018-2023)
Table 28. Global Market Inactivated Porcine Parvovirus Vaccine Price by Company (2018-2023) & (US$/K Doses)
Table 29. Global Inactivated Porcine Parvovirus Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Inactivated Porcine Parvovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Inactivated Porcine Parvovirus Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Inactivated Porcine Parvovirus Vaccine Market
Table 33. Key Manufacturers Inactivated Porcine Parvovirus Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Inactivated Porcine Parvovirus Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2033
Table 36. Global Inactivated Porcine Parvovirus Vaccine Sales by Region (2018-2023) & (M Doses)
Table 37. Global Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Region (2018-2023)
Table 38. Global Inactivated Porcine Parvovirus Vaccine Sales by Region (2018-2023) & (US$ Million)
Table 39. Global Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Region (2018-2023)
Table 40. Global Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 41. Global Inactivated Porcine Parvovirus Vaccine Sales by Region (2024-2033) & (M Doses)
Table 42. Global Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Region (2024-2033)
Table 43. Global Inactivated Porcine Parvovirus Vaccine Sales by Region (2024-2033) & (US$ Million)
Table 44. Global Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Region (2024-2033)
Table 45. Global Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2024-2033)
Table 46. Global Inactivated Porcine Parvovirus Vaccine Sales by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 47. Global Inactivated Porcine Parvovirus Vaccine Sales by Application (2018-2023) & (M Doses)
Table 48. Global Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Application (2018-2023)
Table 49. Global Inactivated Porcine Parvovirus Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 50. Global Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Application (2018-2023)
Table 51. Global Inactivated Porcine Parvovirus Vaccine Price by Application (2018-2023) & (US$/K Doses)
Table 52. Global Inactivated Porcine Parvovirus Vaccine Sales by Application (2024-2033) & (M Doses)
Table 53. Global Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Application (2024-2033)
Table 54. Global Inactivated Porcine Parvovirus Vaccine Sales by Application (2024-2033) & (US$ Million)
Table 55. Global Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Application (2024-2033)
Table 56. Global Inactivated Porcine Parvovirus Vaccine Price by Application (2024-2033) & (US$/K Doses)
Table 57. North America Inactivated Porcine Parvovirus Vaccine Sales by Application (2018-2023) (M Doses)
Table 58. North America Inactivated Porcine Parvovirus Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 59. Europe Inactivated Porcine Parvovirus Vaccine Sales by Application (2018-2023) (M Doses)
Table 60. Europe Inactivated Porcine Parvovirus Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 61. Asia-Pacific Inactivated Porcine Parvovirus Vaccine Sales by Application (2018-2023) (M Doses)
Table 62. Asia-Pacific Inactivated Porcine Parvovirus Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 63. Latin America Inactivated Porcine Parvovirus Vaccine Sales by Application (2018-2023) (M Doses)
Table 64. Latin America Inactivated Porcine Parvovirus Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 65. Middle East and Africa Inactivated Porcine Parvovirus Vaccine Sales by Application (2018-2023) (M Doses)
Table 66. Middle East and Africa Inactivated Porcine Parvovirus Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 67. North America Inactivated Porcine Parvovirus Vaccine Sales by Country (2018-2023) & (M Doses)
Table 68. North America Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Country (2018-2023)
Table 69. North America Inactivated Porcine Parvovirus Vaccine Sales by Country (2018-2023) & (US$ Million)
Table 70. North America Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Country (2018-2023)
Table 71. North America Inactivated Porcine Parvovirus Vaccine Sales by Country (2024-2033) & (M Doses)
Table 72. North America Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Country (2024-2033)
Table 73. North America Inactivated Porcine Parvovirus Vaccine Sales by Country (2024-2033) & (US$ Million)
Table 74. North America Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Country (2024-2033)
Table 75. Europe Inactivated Porcine Parvovirus Vaccine Sales by Country (2018-2023) & (M Doses)
Table 76. Europe Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Country (2018-2023)
Table 77. Europe Inactivated Porcine Parvovirus Vaccine Sales by Country (2018-2023) & (US$ Million)
Table 78. Europe Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Country (2018-2023)
Table 79. Europe Inactivated Porcine Parvovirus Vaccine Sales by Country (2024-2033) & (M Doses)
Table 80. Europe Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Country (2024-2033)
Table 81. Europe Inactivated Porcine Parvovirus Vaccine Sales by Country (2024-2033) & (US$ Million)
Table 82. Europe Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Country (2024-2033)
Table 83. Asia-Pacific Inactivated Porcine Parvovirus Vaccine Sales by Region (2018-2023) & (M Doses)
Table 84. Asia-Pacific Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Region (2018-2023)
Table 85. Asia-Pacific Inactivated Porcine Parvovirus Vaccine Sales by Region (2018-2023) & (US$ Million)
Table 86. Asia-Pacific Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Region (2018-2023)
Table 87. Asia-Pacific Inactivated Porcine Parvovirus Vaccine Sales by Region (2024-2033) & (M Doses)
Table 88. Asia-Pacific Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Region (2024-2033)
Table 89. Asia-Pacific Inactivated Porcine Parvovirus Vaccine Sales by Region (2024-2033) & (US$ Million)
Table 90. Asia-Pacific Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Region (2024-2033)
Table 91. Latin America Inactivated Porcine Parvovirus Vaccine Sales by Country (2018-2023) & (M Doses)
Table 92. Latin America Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Country (2018-2023)
Table 93. Latin America Inactivated Porcine Parvovirus Vaccine Sales by Country (2018-2023) & (US$ Million)
Table 94. Latin America Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Country (2018-2023)
Table 95. Latin America Inactivated Porcine Parvovirus Vaccine Sales by Country (2024-2033) & (M Doses)
Table 96. Latin America Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Country (2024-2033)
Table 97. Latin America Inactivated Porcine Parvovirus Vaccine Sales by Country (2024-2033) & (US$ Million)
Table 98. Latin America Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Country (2024-2033)
Table 99. Middle East and Africa Inactivated Porcine Parvovirus Vaccine Sales by Country (2018-2023) & (M Doses)
Table 100. Middle East and Africa Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Country (2018-2023)
Table 101. Middle East and Africa Inactivated Porcine Parvovirus Vaccine Sales by Country (2018-2023) & (US$ Million)
Table 102. Middle East and Africa Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Country (2018-2023)
Table 103. Middle East and Africa Inactivated Porcine Parvovirus Vaccine Sales by Country (2024-2033) & (M Doses)
Table 104. Middle East and Africa Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Country (2024-2033)
Table 105. Middle East and Africa Inactivated Porcine Parvovirus Vaccine Sales by Country (2024-2033) & (US$ Million)
Table 106. Middle East and Africa Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Country (2024-2033)
Table 107. Merck Animal Health Company Information
Table 108. Merck Animal Health Introduction and Business Overview
Table 109. Merck Animal Health Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 110. Merck Animal Health Inactivated Porcine Parvovirus Vaccine Product
Table 111. Merck Animal Health Recent Development
Table 112. HIPRA Company Information
Table 113. HIPRA Introduction and Business Overview
Table 114. HIPRA Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 115. HIPRA Inactivated Porcine Parvovirus Vaccine Product
Table 116. HIPRA Recent Development
Table 117. Zoetis Company Information
Table 118. Zoetis Introduction and Business Overview
Table 119. Zoetis Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 120. Zoetis Inactivated Porcine Parvovirus Vaccine Product
Table 121. Zoetis Recent Development
Table 122. Ceva Company Information
Table 123. Ceva Introduction and Business Overview
Table 124. Ceva Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 125. Ceva Inactivated Porcine Parvovirus Vaccine Product
Table 126. Ceva Recent Development
Table 127. Bioveta Company Information
Table 128. Bioveta Introduction and Business Overview
Table 129. Bioveta Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 130. Bioveta Inactivated Porcine Parvovirus Vaccine Product
Table 131. Bioveta Recent Development
Table 132. Boehringer Ingelheim Company Information
Table 133. Boehringer Ingelheim Introduction and Business Overview
Table 134. Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 135. Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Product
Table 136. Boehringer Ingelheim Recent Development
Table 137. Harbin Pharmaceutical Group Company Information
Table 138. Harbin Pharmaceutical Group Introduction and Business Overview
Table 139. Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 140. Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Product
Table 141. Harbin Pharmaceutical Group Recent Development
Table 142. Wuhan Keqian Biology Company Information
Table 143. Wuhan Keqian Biology Introduction and Business Overview
Table 144. Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 145. Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Product
Table 146. Wuhan Keqian Biology Recent Development
Table 147. DHN Company Information
Table 148. DHN Introduction and Business Overview
Table 149. DHN Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 150. DHN Inactivated Porcine Parvovirus Vaccine Product
Table 151. DHN Recent Development
Table 152. China Animal Husbandy Industry Company Information
Table 153. China Animal Husbandy Industry Introduction and Business Overview
Table 154. China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 155. China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Product
Table 156. China Animal Husbandy Industry Recent Development
Table 157. Qilu Animal Health Products Factorys Company Information
Table 158. Qilu Animal Health Products Factorys Introduction and Business Overview
Table 159. Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 160. Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Product
Table 161. Qilu Animal Health Products Factorys Recent Development
Table 162. Shandong HuaHong Biological Engineering Company Information
Table 163. Shandong HuaHong Biological Engineering Introduction and Business Overview
Table 164. Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 165. Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Product
Table 166. Shandong HuaHong Biological Engineering Recent Development
Table 167. Shanghai Hile Biological Company Information
Table 168. Shanghai Hile Biological Introduction and Business Overview
Table 169. Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 170. Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Product
Table 171. Shanghai Hile Biological Recent Development
Table 172. Liaoning Yikang Biological Company Information
Table 173. Liaoning Yikang Biological Introduction and Business Overview
Table 174. Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 175. Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Product
Table 176. Liaoning Yikang Biological Recent Development
Table 177. Jilin Zhengye Biological Product Company Information
Table 178. Jilin Zhengye Biological Product Introduction and Business Overview
Table 179. Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 180. Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Product
Table 181. Jilin Zhengye Biological Product Recent Development
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Inactivated Porcine Parvovirus Vaccine Market Trends
Table 185. Inactivated Porcine Parvovirus Vaccine Market Drivers
Table 186. Inactivated Porcine Parvovirus Vaccine Market Challenges
Table 187. Inactivated Porcine Parvovirus Vaccine Market Restraints
Table 188. Inactivated Porcine Parvovirus Vaccine Distributors List
Table 189. Inactivated Porcine Parvovirus Vaccine Downstream Customers
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Inactivated Porcine Parvovirus Vaccine Product Picture
Figure 2. Global Inactivated Porcine Parvovirus Vaccine Market Size, 2018 VS 2022 VS 2033 (US$ Million)
Figure 3. Global Inactivated Porcine Parvovirus Vaccine Market Size Status and Outlook (2018-2033) & (US$ Million)
Figure 4. Global Inactivated Porcine Parvovirus Vaccine Sales Status and Outlook (2018-2033) & (M Doses)
Figure 5. Product Picture of <107.0 TCID50/mL
Figure 6. Global <107.0 TCID50/mL Sales YoY Growth (2018-2033) & (M Doses)
Figure 7. Product Picture of ≥107.0 TCID50/mL
Figure 8. Global ≥107.0 TCID50/mL Sales YoY Growth (2018-2033) & (M Doses)
Figure 9. Global Inactivated Porcine Parvovirus Vaccine Sales by Type (2018-2033) & (US$ Million)
Figure 10. Global Inactivated Porcine Parvovirus Vaccine Sales Market Share by Type in 2022 & 2033
Figure 11. North America Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Inactivated Porcine Parvovirus Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Inactivated Porcine Parvovirus Vaccine Revenue in 2022
Figure 23. Inactivated Porcine Parvovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Sows
Figure 25. Global Sows Sales YoY Growth (2018-2033) & (M Doses)
Figure 26. Product Picture of Gilts
Figure 27. Global Gilts Sales YoY Growth (2018-2033) & (M Doses)
Figure 28. Product Picture of Boars
Figure 29. Global Boars Sales YoY Growth (2018-2033) & (M Doses)
Figure 30. Global Inactivated Porcine Parvovirus Vaccine Sales by Application (2018-2033) & (US$ Million)
Figure 31. Global Inactivated Porcine Parvovirus Vaccine Sales Market Share by Application in 2022 & 2033
Figure 32. North America Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. North America Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Europe Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Europe Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Latin America Inactivated Porcine Parvovirus Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Inactivated Porcine Parvovirus Vaccine Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Inactivated Porcine Parvovirus Vaccine Manufacturing Cost Structure
Figure 43. Inactivated Porcine Parvovirus Vaccine Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries